New Improved Drug Delivery Technologies for Pentacyclic Riterpenes: A Review

ISSN: 1875-5305 (Online)
ISSN: 0929-8665 (Print)


Volume 21, 12 Issues, 2014


Download PDF Flyer




Protein & Peptide Letters

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Prof. Ben M. Dunn
Department of Biochemistry and Molecular Biology
University of Florida
College of Medicine
P.O. Box 100245
Gainesville, FL
USA
Email: bdunn@ufl.edu

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.735
5 - Year: 1.493

New Improved Drug Delivery Technologies for Pentacyclic Riterpenes: A Review

Author(s): Codruta Soica, Cristina Trandafirescu, Corina Danciu, Danina Muntean, Cristina Dehelean and Georgeta Simu

Affiliation: Faculty of Pharmacy, University of Medicine and Pharmacy „Victor Babes”Timisoara

Abstract

Phytochemicals are becoming more and more interesting in the field of therapeutic research, mainly in the treatment of chronic illnesses, due to the fact that many synthetic drugs cause important side effects that impact on patient’s life quality. Pentacyclic triterpenes are a class of compounds with several therapeutic effects and increasing importance in cancer therapy; however, a major disadvantage is their low water solubility and bioavailability which leads to rather poor therapeutic results in vivo. Technological attempts to improve the pharmacokinetic profile of the main representatives of this class include the use of cyclodextrins, micro- and nanoemulsions, liposomes, polymeric nanoparticles, and nanocapsules. This paper is aimed to briefly summarize the most significant achievements in this field


Purchase Online Rights and Permissions

  
  



Article Details

Volume: 21
First Page: 1
Page Count: 1
DOI: 10.2174/0929866521666140807115109
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science